SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout!
LGND 202.50-2.7%Nov 7 9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Henry Niman who wrote (27372)1/12/1999 1:17:00 PM
From: medsunman  Read Replies (5) of 32384
 
Henry: Just a short note before I return to H&Q. You are right, Robinson and Negro-Vilar due have high expectaions for the androgen program. This technology has the potential to address several very large markets. I got the impression that there are at least one of two compounds ready for human testing in this program, but LGND is forestalling this so as not to derail their march to profitability. I think the androgen program, as well as several other programs LGND has in development may be big successes after 2002-2003, but I try not to look that far ahead. I hope that the Q4 profit will produce black ink for the entire year, but I am not sure that I heard Robinson say that.
I hope I wasn't too negative in my last post, because I didn't intend it that way. I said I wasn't real impressed with the presentation - what I meant was that there really wasn't much new. It was pretty much the same info we already have, that's all.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext